Molecular risk factors
Showing 1 - 25 of >10,000
Development of Gastric Cancer
Recruiting
- Gastric Cancer
- Molecular testing for all participants.
- +2 more
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
Jan 23, 2023
Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing
Recruiting
- Medulloblastoma
- +5 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hosiptal
Jan 3, 2023
Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)
Not yet recruiting
- Cardiovascular Risk
- Plant Omega
- Dietary therapy only
-
Petaling Jaya, Selangor, MalaysiaBeacon Hospital Sdn Bhd
May 21, 2023
Human Papilloma Virus Infection Trial in Jakarta (HPV Diagnostic Kit (Bio Farma))
Completed
- Human Papilloma Virus Infection
- HPV Diagnostic Kit (Bio Farma)
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo Hospital
Oct 26, 2023
D-dimer Combined With Other Thrombus Molecular Markers in Risk
Not yet recruiting
- Venous Thromboembolic Disease
- Venous blood was collected from patients under fasting state to detect the level of thrombus molecular markers
-
Jinan, Shan Dong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Aug 24, 2022
stratification of High-risk Intestinal Metaplasia (GCEP2 Study)
Recruiting
- Stomach Neoplasm
- Blood Collection, processing and analyses
- +2 more
-
Stanford, California
- +7 more
Mar 13, 2023
Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)
Not yet recruiting
- Colorectal Cancer
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 31, 2023
Abortion, Spontaneous Trial in Napoli (high molecular weight hyaluronic acid, a-lipoic acid (ALA), magnesium, vitamin B6 and
Recruiting
- Abortion, Spontaneous
- high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D
-
Napoli, ItalyDipartimento di Neuroscienze e Scienze riproduttive ed odontosto
Dec 22, 2022
Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission
Recruiting
- Solid Tumor, Unspecified, Adult
- 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
-
Meldola, Forlì Cesena, ItalyIRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
Nov 15, 2023
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)
Not yet recruiting
- Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
- Monalizumab
- Cetuximab
- (no location specified)
Jan 8, 2023
Medulloblastoma Trial in Memphis (procedure, drug, radiation)
Recruiting
- Medulloblastoma
- Surgical resection
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 16, 2022
Predictors of Node Positivity in Endometrial Cancer
Not yet recruiting
- Endometrial Cancer
- (no location specified)
Mar 29, 2023
Based on Molecular Typing of Medulloblastoma in Children
Not yet recruiting
- Medulloblastoma, Childhood
- Prospective observational study, no intervention
- (no location specified)
Jun 4, 2022
Cigarette Smoking-Related Carcinoma, Lung Carcinoma Trial in Columbus (procedure, biological, other)
Not yet recruiting
- Cigarette Smoking-Related Carcinoma
- Lung Carcinoma
- Biospecimen Collection
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 6, 2023
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk
Recruiting
- Early-Stage Breast Cancer
- Neoadjuvant Therapy
- Genomic Profiling / Sequencing
-
Berlin, Germany
- +4 more
Jun 19, 2023
Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)
Recruiting
- Locally Advanced Breast Cancer
- Hormone Receptor Positive，HER2-negative Breast Cancer
-
Jinan, Shandong, ChinaBreast Cancer Center, Shandong Cancer Hospital and Institute
Apr 11, 2023
Estimate Risk of Cancer in Gynecology Patients Presenting
Completed
- Ovarian Neoplasms
- Pelvic imaging
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center Wilmot Cancer Institute
Jun 27, 2022
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
Intracranial Atherosclerosis Trial in Chicago (Feraheme)
Recruiting
- Intracranial Atherosclerosis
-
Chicago, IllinoisNorthwestern University
Aug 22, 2022
Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)
Recruiting
- Lupus Nephritis
- 68Ga-FAPI-04 PET
-
Shanghai, ChinaRuijin Hospital
May 4, 2023
Prostate Cancer Trial in Aarhus N (Genetic risk assessment)
Active, not recruiting
- Prostate Cancer
- Genetic risk assessment
-
Aarhus N, Aarhus, DenmarkDepartment of Molecular Medicine
May 18, 2022
Liquid Biopsies and Tumor Molecular Profiling in Predicting
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +5 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022